ObjectivesObjectivesAt the completion of this session the participant will be able to:◦Describe the occupational exposure risks of chemotherapy/biotherapy
◦List components of safe handling and disposal practices
◦Identify components of personal protection equipment
Safe Handling 2
IntroductionIntroductionChemotherapeutic agents are
used successfully to treat a variety of malignancies - these agents may also cause malignancy in individuals who handle them
The Occupational Safety and Health Administration (OSHA) (1995), reports that safe levels of occupational exposure to cytotoxic agents cannot be determined and no reliable method of monitoring exists
Safe Handling 3
IntroductionIntroductionThe National Institute for Occupational
Safety and Health (NIOSH) reports in studies that there is evidence of health risk, and safe levels of exposure to cytotoxic agents have not been determined by a reliable method (NIOSH, 2004).
Biotheraputic agents also can be associated with exposure risks. OSHA also has classified them as hazardous materials Use safe handling for any biotherapy agent labeled hazardous by the manufacturer or OSHA (e.g., interferon) (NIOSH, 2004).
Safe Handling 4
Occupational Occupational Exposure RiskExposure RiskHealth care workers handling
chemotherapy and biotherapy agents are at risk for occupational exposure to these toxins, and the long-term effects are unknown
Safe Handling 5
Occupational Occupational Exposure RiskExposure Risk
The potential health risks include: ◦Carcinogenicity◦Genotoxicity◦Teratogenicity◦Organ toxicity◦Acute symptoms such as headache,
nausea, dizziness and skin, eye or throat irritation
(Valanis, Vollmer, Labuhn, & Glass, 1993) Safe Handling 6
Occupational Occupational Exposure RiskExposure Risk
The potential routes of exposure are◦Injection through needle stick◦Ingestion: direct or through food or beverage
◦Inhalation of drug by aerosolization
◦Absorption through mucous membranes after direct contact
Safe Handling 7
Safe Handling Safe Handling PolicyPolicy
Institutions are required by OSHA to develop and implement policies regarding the safe handling of cytotoxic and biologic agents
Safe Handling 8
Safe Handling Safe Handling PolicyPolicyProtection measures must include at a minimum:◦Safe administration, storage, transport
and disposal of hazardous agents◦Provision of mandatory training of
employees regarding hazardous materials
◦Monitoring of long term occupational exposure and minimization of employee risk
◦Hazardous drug spill management
Safe Handling 9
Safe Handling Safe Handling PolicyPolicyProtection measures must include at a minimum:◦Prohibition of eating, drinking, chewing
gum, storing food, and applying cosmetics in areas where cytotoxic/biologic agents are prepared or administered
◦Provision of protection for employees who are pregnant, breast-feeding or planning a pregnancy
◦Monitoring compliance with the above indicated institutional policies and procedures
Safe Handling 10
Exposure Protection Exposure Protection GuidelinesGuidelinesPersonal Protective Equipment (PPE) is to
be used whenever there is a possibility of cytotoxic/biologic agents being released into the environment. This includes: ◦ Preparing or transferring
medications from vials, or ampoules; spiking, priming or changing IV equipment
◦ Expelling air or transferring medications using needles or syringes
Safe Handling 11
Exposure Protection Exposure Protection GuidelinesGuidelinesPPE usage (continued):
◦Contact with leaking tubing or connection sites
◦Managing cytotoxic spills◦Disposing of cytotoxic/biologic agents and mixing materials
◦When handling the body fluids of a patient for 48 hours after they receive chemotherapy
Safe Handling 12
Exposure Protection Exposure Protection GuidelinesGuidelinesPPE includes:
◦Gloves◦Gowns◦Face shield or goggles
Safe Handling 13
Exposure Protection Exposure Protection GuidelinesGuidelines
Labeling and Storage ◦Medications must be
clearly labeled for content and hazardous nature
◦Material Safety Data Sheets (MSDS) must be available for all medications
◦Any area that contains chemotherapeutic materials must be inaccessible to children with locked entry
Safe Handling 14
Exposure Protection Exposure Protection GuidelinesGuidelinesAdministration:
◦Obtain medication◦Wash hands and don PPE◦Place a sterile, plastic-backed
absorbent pad on the work surface◦Always work below eye level◦Ampoules: wrap absorbent sterile
pad around the neck of the ampoule and break away from yourself. Use a filtered straw for withdrawal
Safe Handling 15
Exposure Protection Exposure Protection GuidelinesGuidelines
Administration:◦Packaged medications, oral tablets and
capsules: avoid aerosolization, which results from pressure. Use venting devises to release the pressure. Capsules and tablets should be crushed under a BSC
◦Wear gloves when mixing agents that cause skin or other irritation (e.g., rituximab).
◦Do not overfill syringes to prevent the plunger from separating
Safe Handling 16
Exposure Protection Exposure Protection GuidelinesGuidelines
Administration:◦Excess medication or air contained
within a needleless syringe should never be expressed into the air, but should instead be expressed directly into a sterile gauze pad that is placed in a sealable plastic bag
◦Sterile technique should be maintained throughout parenteral drug preparation
Safe Handling 17
Exposure Exposure Protection Protection GuidelinesGuidelinesAdministration:◦ IV tubing should be primed
under a hood or be primed with 10-20ml of compatible solution using the backflow method
◦ IV tubing should have Luer-lock connections
◦ Wipe the tubing or syringe with moist gauze then place in a sealable plastic bag for transport
Safe Handling18
Exposure Protection Exposure Protection GuidelinesGuidelines
Administration:◦An absorbent pad with a plastic back
is necessary for collecting any spill that may occur when connecting the tubing to the patient
◦A cytotoxic medication caution label is attached to the IV set for the duration of the chemotherapeutic/cytotoxic/biologic agent infusion
Safe Handling 19
Exposure Protection Exposure Protection GuidelinesGuidelines
Administration:◦ After administration, remove the IV bag with the
tubing attached (NIOSH, 2004). Do not remove the spike from the bag or reuse the tubing.
◦ Dispose of all equipment that has come in contact with the hazardous drug by placing the equipment in a container labeled “cytotoxic waste.”
◦ Use detergent and water to clean surfaces that have been in contact with hazardous drugs (Polovich, 2004).
◦ Remove and discard PPE◦ Wash your hands before leaving the preparation
and administration area
Safe Handling 20
Exposure Protection Exposure Protection GuidelinesGuidelinesAdministration
Review hospital-specific administration guidelines
Safe Handling 21
Exposure Protection Exposure Protection GuidelinesGuidelines
Disposal Guidelines◦Hazardous medical waste
containers must be available in all areas where hazardous medications are prepared and administered (NIOSH, 2004).
◦The waste containers should be puncture-proof, have a secure lid, and be clearly labeled as hazardous waste.
◦ Unused medicine returned to pharmacy
Safe Handling 22
Exposure Protection Exposure Protection GuidelinesGuidelinesBody Fluid Guidelines
◦Utilize PPE and standard universal precautions when handling patient’s body fluid or lines for 48 hours after administration of chemotherapy
◦Patients may use regular bathroom facilities
Safe Handling 23
Exposure Protection Exposure Protection GuidelinesGuidelines
Body Fluid Guidelines◦Diapers should be disposed of in the
same manner as other hazardous waste by placing them in appropriately labeled plastic hazardous waste bags
◦Bedpans, hats, urinals and emesis basins that are rinsed carefully with soap and water may be reused. After use, they should be discarded in the hazardous waste receptacle.
Safe Handling 24
Exposure Protection Exposure Protection GuidelinesGuidelines
Body Fluid Guidelines◦Linens that are contaminated with
body fluids should be placed in a plastic bag and labeled as contaminated by chemotherapy before placing them with other hospital laundry
◦The toilet should be flushed twice with the lid down after disposing of excreta from these patients for 48 hours following chemotherapy administration Safe Handling 25
Exposure Protection Exposure Protection GuidelinesGuidelinesSpill Guidelines
◦Spill kits should be available in all areas where cytotoxic drugs are stored, prepared, transported, and administered
◦Only trained personnel with appropriate PPE should clean up cytotoxic spills
Safe Handling 26
Exposure Protection Exposure Protection GuidelinesGuidelinesSpill Guidelines
Review hospital-specific spill kit and policy
Safe Handling 28
Safe Handling at Safe Handling at HomeHomePrecautions for family members to protect themselves from exposure ◦Pregnant caregivers should not mix or handle cytotoxic agents without appropriate PPE and education
◦Protective equipment use is demonstrated and a return demonstration given by the caregiver
Safe Handling 29
Safe Handling at Safe Handling at HomeHomePrecautions for family members to protect themselves from exposure ◦Designate a workplace in the home for handling cytotoxic agents
◦Special instructions for crushing tablets or opening capsules must be instituted in the home setting to protect caregivers and family members
Safe Handling 30
Safe Handling at Safe Handling at HomeHomeEmergency interventions and reporting mechanisms for accidental drug exposure◦Medication-specific exposure hazards reported by the manufacturer should be reviewed with the caregiver
◦Types of exposures and prevention/ precautions such as inhalation, splash, spill are reviewed with the caregiver
Safe Handling 31
Safe Handling at Safe Handling at HomeHomeEmergency interventions and reporting mechanisms for accidental drug exposure◦ Teaching sheets reviewed by the RN with the
caregiver must include safeguards such as: What to do for skin contact, eye contact
and environmental/clothing contact How to clean up a spill and dispose of
contaminated material Who to call and include the telephone
numbers
Safe Handling 32
Safe Handling at Safe Handling at HomeHomeSafe disposal of utensils, capsule remnants and contaminated materials◦Protection of children and pets in the
home from exposure to cytotoxic medication or waste products
◦Demonstration of appropriate disposable equipment should be provided to the caregiver
◦Explanation of safe disposal with specific individualized home setting considerations, as well as, county and state regulations
Safe Handling 33
Safe Handling at Safe Handling at HomeHome
Review hospital-specific teaching materials for
administering chemotherapy at home
Safe Handling 34